Toutes les études
RecrutementPharmacologie humaine (Phase I) - Première administration chez l'hommeInterventionnel

A clinical study investigating OM-85-IN safety and tolerability in healthy volunteers and mild allergic asthma patients

This research study is investigating a new treatment called OM-85-IN. It's specifically for people who have mild allergic asthma. The study also includes healthy volunteers, who don't have asthma. The main purpose of this early-stage study is to carefully check if the treatment is safe for people to take and to see how their bodies react to it. This means researchers will be looking for any side effects and how well people cope with the new medication. This kind of study is a crucial first step when developing new medicines, ensuring they are safe before they can be tested on more people.

En un coup d'œil

Statut
Recrutement
Phase
Pharmacologie humaine (Phase I) - Première administration chez l'homme
Sponsor
OM Pharma S.A.
Objectif d'inscription
41
Démarrer
17 oct. 2023

De quoi parle cette étude ?

You've landed on information about a research study looking into a new potential treatment called OM-85-IN. Think of it like a brand new recipe that hasn't been tried out much yet. Scientists have developed this new treatment and believe it might help conditions like mild allergic asthma.

The main aim of this particular study is very straightforward: to see if this new treatment is safe for people to take and to understand how their bodies react to it. This is called 'safety and tolerability'. It's the very first time this treatment is being given to humans, which is a big and important step in developing new medicines. They want to make sure it doesn't cause any serious problems and that people can take it without too many uncomfortable side effects.

By carefully studying how healthy volunteers and people with mild allergic asthma react to OM-85-IN, researchers can gather vital information. This helps them decide if the treatment is promising enough to continue with further, larger studies in the future, which would then look into whether it actually works to improve asthma symptoms.

Points clés

  • This study is testing a new treatment called OM-85-IN for safety.
  • It's open to healthy adults and those with mild allergic asthma.
  • This is an early-stage study, the first time it will be given to people.
  • Participation involves clinic visits and careful health monitoring.
  • You have the right to leave the study at any time.
  • The main aim is to understand side effects, not to cure asthma.

Qui peut être éligible ?

To join this study, you would need to be an adult, aged 18 years or older. There is no upper age limit for taking part.

The study is looking for two main groups of people: healthy volunteers who don't have any significant health problems, and people who have been diagnosed with mild allergic asthma. This means your asthma symptoms are generally mild and often triggered by things like pollen, dust mites, or pet dander.

Both men and women are welcome to participate in this study. The research team will have a more detailed list of things that might make someone suitable or unsuitable, so if you're interested, it's best to speak with them directly or with your GP.

Cet étude pourrait-elle vous convenir ?

Répondez à ces questions rapides pour voir si vous êtes éligible. Ceci est un guide uniquement — l'équipe de recherche prend la décision finale.

  1. Avez-vous 18 ans ou plus ?
  2. Do you have mild allergic asthma, or are you generally healthy?
  3. Are you able to attend appointments at a study clinic?
  4. Are you comfortable with taking a new, experimental medication?
  5. Êtes-vous un homme ou une femme ?
Répondez à chaque question pour voir votre résultat.

En quoi consiste la participation ?

Taking part in this study would involve a series of visits to a clinic or research centre. During these visits, the research team would carry out different assessments, which might include health check-ups, blood tests, and possibly breathing tests if you have asthma. You would receive the study medication (OM-85-IN) during these visits, and the team would closely monitor how you are feeling and reacting to it. You would also have follow-up appointments to ensure everything is well after you've taken the medication. The total duration of your participation, including all visits and follow-ups, would be explained in full by the research team.

Risques et avantages potentiels

Potential benefits of taking part could include contributing to medical science and helping to develop new treatments for asthma, which might help others in the future. You would also receive regular health check-ups during the study. As this is a very early-stage study, the main risk is that the new treatment might cause unexpected side effects, some of which could be uncomfortable or, very rarely, more serious. The research team will explain all known potential risks in detail. Remember, your participation is completely voluntary, and you have the right to withdraw from the study at any time, for any reason, without it affecting your usual medical care.

Emplacements (1)

Certains emplacements de site sont approximatifs. Nous améliorons cela — veuillez vérifier avec l'équipe d'essai avant de vous déplacer.
  • —
    Non vérifié
    Allemagne

Questions fréquentes

What is 'mild allergic asthma'?

Mild allergic asthma means your asthma symptoms are usually mild and are often triggered by things you're allergic to, like pollen, dust, or pet dander.

What does a 'Human Pharmacology (Phase I)' study mean?

This is the very first time a new medicine is given to people. The main goal is to check how safe it is and how people's bodies react to it, rather than seeing if it cures a condition.

Serai-je payé pour participer ?

Some studies offer payment for your time and travel, but this varies. The study team will tell you if this is the case.

What is OM-85-IN?

OM-85-IN is the name of the new treatment being tested. It's an investigational medicine, meaning it's still being studied and is not yet available as a standard treatment.

Will my regular doctor know I'm in the study?

It's usually a good idea to tell your regular doctor you're thinking about joining a study, so they can advise you. The study team may also ask for your permission to inform your doctor.

Comment en savoir plus

Parlez toujours à votre médecin généraliste ou spécialiste avant de décider de participer à une étude.

Intéressé à participer ?

Inscrivez votre intérêt

Partagez vos coordonnées et l'équipe de recherche pour "A clinical study investigating OM-85-IN safety and tolerabil… vous contactera si vous êtes éligible. Consultez toujours votre médecin avant d'accepter de participer.

Discussion

Discussion communautaire

Propulsé par notre forum à community.patient.info. Veuillez être respectueux — ceci n'est pas un avis médical.